John Voris
Mr. Voris is currently CEO and a member of the board of HAPC, Inc., a publicly traded special purpose acquisition company focused on healthcare (HAPNU:OB). He is also serving on the boards of directors of Epocrates, Inc., Oscient Pharmaceuticals (NASDAQ:OSCI), Gentiae Clinical Research, and Regenesis Biomedical. His previous work experience included the positions of Chairman, President, and CEO of Epocrates, a successful venture backed medical software company providing clinical information to healthcare professionals at the point of care. Prior to Epocrates, Voris spent 26 years with Eli Lilly and Company in a variety of senior positions in business unit management, business development, international management, and domestic sales and marketing. He received his B.S. and M.B.A. from the Kelley School of Business, Indiana University.
Additional Information
No additional information has been added yet. Add a LinkedIn URL.
Invested In
No investments.